Skip to main content
Top
Published in: World Journal of Surgery 5/2020

Open Access 01-05-2020 | Candidiasis | Original Scientific Report

Appropriate Source Control and Antifungal Therapy are Associated with Improved Survival in Critically Ill Surgical Patients with Intra-abdominal Candidiasis

Authors: Ting Yan, Shuang-Ling Li, Hai-Li Ou, Sai-Nan Zhu, Lei Huang, Dong-Xin Wang

Published in: World Journal of Surgery | Issue 5/2020

Login to get access

Abstract

Background

Intra-abdominal candidiasis (IAC) is the predominant type of invasive candidiasis with high mortality in surgical intensive care patients. The purpose of this study was to investigate the impact of appropriate source control and antifungal therapy on the outcomes of critically ill surgical patients with IAC.

Methods

This was a retrospective single-center cohort study. Adult surgical patients who were admitted to the intensive care unit and diagnosed with IAC from January 1, 2003, to December 31, 2016, were enrolled. The patients’ data including risk factors of IAC, infection-related information, antifungal treatment and 30-day outcomes were collected. The primary endpoint was 30-day mortality. A COX proportional hazards model was used to analyze the association between appropriate treatment and 30-day survival.

Results

A total of 82 patients were included in the analysis. Of these, 45 (54.9%) were complicated with septic shock at IAC diagnosis. Types of IAC included peritonitis (61.0%), intra-abdominal abscesses (23.2%) and biliary tract infections (15.9%). Of the included patients, 53 (64.6%) received appropriate source control and 44 (53.7%) appropriate antifungal therapy. Compared with patients with neither of these treatments, appropriate source control (HR 0.08, 95% CI 0.02–0.30; P < 0.001), appropriate antifungal therapy (HR 0.14, 95% CI 0.04–0.55; P = 0.005), and a combination of these treatments (HR 0.02, 95% CI 0.00–0.08; P < 0.001) were associated with reduced risk of death within 30 days after IAC diagnosis.

Conclusion

For critically ill surgical patients with IAC, both appropriate source control and appropriate antifungal therapy were associated with reduced risk of 30-day mortality, and the protective effects of the two appropriate treatments were additive.
Literature
1.
go back to reference Aguilar G, Delgado C, Corrales I et al (2015) Epidemiology of invasive candidiasis in a surgical intensive care unit: an observational study. BMC Res Notes 8:491CrossRef Aguilar G, Delgado C, Corrales I et al (2015) Epidemiology of invasive candidiasis in a surgical intensive care unit: an observational study. BMC Res Notes 8:491CrossRef
2.
go back to reference Leroy O, Gangneux JP, Montravers P et al (2009) Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005–2006). Crit Care Med 37:1612–1618CrossRef Leroy O, Gangneux JP, Montravers P et al (2009) Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005–2006). Crit Care Med 37:1612–1618CrossRef
3.
go back to reference de Ruiter J, Weel J, Manusama E et al (2009) The epidemiology of intra-abdominal flora in critically ill patients with secondary and tertiary abdominal sepsis. Infection 37:522–527CrossRef de Ruiter J, Weel J, Manusama E et al (2009) The epidemiology of intra-abdominal flora in critically ill patients with secondary and tertiary abdominal sepsis. Infection 37:522–527CrossRef
4.
go back to reference Montravers P, Dupont H, Gauzit R et al (2006) Candida as a risk factor for mortality in peritonitis. Crit Care Med 34:646–652CrossRef Montravers P, Dupont H, Gauzit R et al (2006) Candida as a risk factor for mortality in peritonitis. Crit Care Med 34:646–652CrossRef
5.
go back to reference Dupont H, Paugam-Burtz C, Muller-Serieys C et al (2002) Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients. Arch Surg 137:1341–1346CrossRef Dupont H, Paugam-Burtz C, Muller-Serieys C et al (2002) Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients. Arch Surg 137:1341–1346CrossRef
6.
go back to reference Bassetti M, Righi E, Ansaldi F et al (2015) A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med 41:1601–1610CrossRef Bassetti M, Righi E, Ansaldi F et al (2015) A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med 41:1601–1610CrossRef
7.
go back to reference Rebolledo M, Sarria JC (2013) Intra-abdominal fungal infections. Curr Opin Infect Dis 26:441–446PubMed Rebolledo M, Sarria JC (2013) Intra-abdominal fungal infections. Curr Opin Infect Dis 26:441–446PubMed
8.
go back to reference Montravers P, Leroy O, Eckmann C (2015) Intra-abdominal candidiasis: it’s still a long way to get unquestionable data. Intensive Care Med 41:1682–1684CrossRef Montravers P, Leroy O, Eckmann C (2015) Intra-abdominal candidiasis: it’s still a long way to get unquestionable data. Intensive Care Med 41:1682–1684CrossRef
9.
go back to reference Montravers P, Dupont H, Eggimann P (2013) Intra-abdominal candidiasis: the guidelines—forgotten non-candidemic invasive candidiasis. Intensive Care Med 39:2226–2230CrossRef Montravers P, Dupont H, Eggimann P (2013) Intra-abdominal candidiasis: the guidelines—forgotten non-candidemic invasive candidiasis. Intensive Care Med 39:2226–2230CrossRef
10.
go back to reference Kollef M, Micek S, Hampton N et al (2012) Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis 54:1739–1746CrossRef Kollef M, Micek S, Hampton N et al (2012) Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis 54:1739–1746CrossRef
11.
go back to reference Morrell M, Fraser VJ, Kollef MH (2005) Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49:3640–3645CrossRef Morrell M, Fraser VJ, Kollef MH (2005) Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49:3640–3645CrossRef
12.
go back to reference Grim SA, Berger K, Teng C et al (2012) Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes. J Antimicrob Chemother 67:707–714CrossRef Grim SA, Berger K, Teng C et al (2012) Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes. J Antimicrob Chemother 67:707–714CrossRef
13.
go back to reference Ostrosky-Zeichner L, Kullberg BJ, Bow EJ et al (2011) Early treatment of candidemia in adults: a review. Med Mycol 49:113–120CrossRef Ostrosky-Zeichner L, Kullberg BJ, Bow EJ et al (2011) Early treatment of candidemia in adults: a review. Med Mycol 49:113–120CrossRef
14.
go back to reference Vergidis P, Clancy CJ, Shields RK et al (2016) Intra-abdominal candidiasis: the importance of early source control and antifungal treatment. PLoS ONE 11:e0153247CrossRef Vergidis P, Clancy CJ, Shields RK et al (2016) Intra-abdominal candidiasis: the importance of early source control and antifungal treatment. PLoS ONE 11:e0153247CrossRef
15.
go back to reference Lagunes L, Rey-Perez A, Martin-Gomez MT et al (2017) Association between source control and mortality in 258 patients with intra-abdominal candidiasis: a retrospective multi-centric analysis comparing intensive care versus surgical wards in Spain. Eur J Clin Microbiol Infect Dis 36:95–104CrossRef Lagunes L, Rey-Perez A, Martin-Gomez MT et al (2017) Association between source control and mortality in 258 patients with intra-abdominal candidiasis: a retrospective multi-centric analysis comparing intensive care versus surgical wards in Spain. Eur J Clin Microbiol Infect Dis 36:95–104CrossRef
16.
go back to reference Dimopoulos G, Matthaiou DK, Righi E et al (2017) Elderly versus non-elderly patients with intra-abdominal candidiasis in the ICU. Minerva Anestesiol 83:1126–1136PubMed Dimopoulos G, Matthaiou DK, Righi E et al (2017) Elderly versus non-elderly patients with intra-abdominal candidiasis in the ICU. Minerva Anestesiol 83:1126–1136PubMed
17.
go back to reference Bassetti M, Marchetti M, Chakrabarti A et al (2013) A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med 39:2092–2106CrossRef Bassetti M, Marchetti M, Chakrabarti A et al (2013) A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med 39:2092–2106CrossRef
18.
go back to reference National Committee for Clinical Laboratory Standards (NCCLS) (1997) Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard-second edition. NCCLS document M27-A NCCLS, Wayne National Committee for Clinical Laboratory Standards (NCCLS) (1997) Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard-second edition. NCCLS document M27-A NCCLS, Wayne
19.
go back to reference Solomkin JS, Ristagno RL, Das AF et al (2013) Source control review in clinical trials of anti-infective agents in complicated intra-abdominal infections. Clin Infect Dis 56:1765–1773CrossRef Solomkin JS, Ristagno RL, Das AF et al (2013) Source control review in clinical trials of anti-infective agents in complicated intra-abdominal infections. Clin Infect Dis 56:1765–1773CrossRef
20.
go back to reference Pappas PG, Kauffman CA, Andes DR et al (2016) Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 62:e1–50CrossRef Pappas PG, Kauffman CA, Andes DR et al (2016) Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 62:e1–50CrossRef
21.
go back to reference Bingold TM, Lefering R, Zacharowski K et al (2015) Individual organ failure and concomitant risk of mortality differs according to the type of admission to ICU—a retrospective study of SOFA score of 23,795 patients. PLoS ONE 10:e0134329CrossRef Bingold TM, Lefering R, Zacharowski K et al (2015) Individual organ failure and concomitant risk of mortality differs according to the type of admission to ICU—a retrospective study of SOFA score of 23,795 patients. PLoS ONE 10:e0134329CrossRef
22.
go back to reference Singer M, Deutschman CS, Seymour CW et al (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:801–810CrossRef Singer M, Deutschman CS, Seymour CW et al (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:801–810CrossRef
23.
go back to reference Mazuski JE, Tessier JM, May AK et al (2017) The surgical infection society revised guidelines on the management of intra-abdominal infection. Surg Infect (Larchmt) 18:1–76CrossRef Mazuski JE, Tessier JM, May AK et al (2017) The surgical infection society revised guidelines on the management of intra-abdominal infection. Surg Infect (Larchmt) 18:1–76CrossRef
24.
go back to reference Maseda E, Rodríguez-Manzaneque M, Dominguez D et al (2016) Intraabdominal candidiasis in surgical ICU patients treated with anidulafungin: a multicenter retrospective study. Rev Esp Quimioter 29:32–39PubMed Maseda E, Rodríguez-Manzaneque M, Dominguez D et al (2016) Intraabdominal candidiasis in surgical ICU patients treated with anidulafungin: a multicenter retrospective study. Rev Esp Quimioter 29:32–39PubMed
25.
go back to reference Perlin DS (2015) Echinocandin resistance in Candida. Clin Infect Dis 61(Suppl 6):S612–S617CrossRef Perlin DS (2015) Echinocandin resistance in Candida. Clin Infect Dis 61(Suppl 6):S612–S617CrossRef
Metadata
Title
Appropriate Source Control and Antifungal Therapy are Associated with Improved Survival in Critically Ill Surgical Patients with Intra-abdominal Candidiasis
Authors
Ting Yan
Shuang-Ling Li
Hai-Li Ou
Sai-Nan Zhu
Lei Huang
Dong-Xin Wang
Publication date
01-05-2020
Publisher
Springer International Publishing
Published in
World Journal of Surgery / Issue 5/2020
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-020-05380-x

Other articles of this Issue 5/2020

World Journal of Surgery 5/2020 Go to the issue